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The ORI Newsletter is interested in providing a forum for occasional commentary by outside experts. Ideas for future newsletters can be submitted to ASKORI.
A Plan to Prevent and Respond to Plagiarism Complaints
Alan J. Evelyn, M.B.A., Baruch College, CUNY As the first Research Integrity Officer (RIO) at Baruch College, I wanted to de velop a framework that would help en gage faculty in discussions about respon sible conduct of research and fulfill my responsibilities for the new City Univer sity of New York (CUNY) policy regard ing the "Disposition of Allegations of Misconduct in Research and Similar Educational Activities."
To better understand what other institutions are doing to foster a culture of research in tegrity, I attended "The First Biennial ORI Conference on Responsible Conduct of Research Education, Instruction and Train ing" (Washington University, April 2008) and "Ethics in Research" (Borough Man hattan Community College, CUNY, Janu ary 2008). One conclusion was inescap able: as a RIO, I will have the most im pact on research behavior and ethical standards in the area of plagiarism. This issue demands to be discussed and as sessed in a contextual framework.
The CUNY policy states that a finding of research misconduct requires that there be "...a significant departure from accepted practices of the Relevant Re search Community (RRC)." Based on this policy, I decided that the RRC would provide the context in which it would be possible to engage and evaluate fac ulty complaints of plagiarism. 
D., University of California (UC), Davis
ORI announces a new on-line educa tional program developed to inspire dis cussion and dialogue about how re searchers can enhance their skills in establishing and running a laboratory or research program. Created for ORI by the Laboratory Management™ Institute at UC Davis, the on-line educational pro gram can be accessed through the ORI web site. The program is intended for re searchers at any level of experience, but especially for those early in their career who may have had little education and experience in establishing and running their own independent research program. Instructional materials also are included for educators who might want to use them in their own programs.
The content of the web-based program centers around managerial and leader ship issues that can arise in running a laboratory or research program. The is sues were selected from those suggested at workshops in laboratory management held at UC Davis, and actually experi enced by postdoctoral scholars, gradu ate students, and researchers in aca demia, government, and industry. The issues filmed include dilemmas in deal ing with difficult people, laboratory (See Research Team, page 3)
The conference is designed for those in terested in learning about the research on research integrity. The content areas of ten examine issues on the incidence of research misconduct, authorship, impact of mentoring, conflict of interest in pub lished studies, ethical decision making, and evaluation of the research climate.
Interactional Video Planned
ORI plans to create an interactive multi media simulation for researchers about ethical decision making, in partnership with the Stockdale Center for Ethical Leadership at the United States Naval Academy and WILL Interactive.
Interactive multimedia simulations allow participants to learn by doing. In this case, participants will play the role of a re searcher faced with possible research mis conduct and the resulting ethical dilem mas. In a realistic environment, participants have to decide what to do. Each choice, and combination of choices, sends the scenario off in a different di rection, with attendant risks and conse quences. Loc Nguyen-Khoa, ORI Project Officer, points out that the practice helps prepare students for making those tough decisions later in their lives.
ORI's partners in this effort bring tested strengths to the table. The Stockdale Cen ter and WILL Interactive have partnered before to produce four simulations on ethical decision making. In this new en deavor, the three partners will work to gether to develop the simulation's story, and then WILL Interactive will bring it to life.
Journal "Audits" of Image Manipulation
The American Thoracic Society (ATS) has recently agreed with two other pub lishers in science and has publicly re vealed the results of journal prescreening for image manipulation. ATS found, in manuscripts accepted by the American Journal of Respiratory Cell and Critical Care Medicine, that "approximately 23% of images had undergone some alteration "including 'erasure,' 'filling in,' 'splicing,' and 'clon ing.'" 1 Separately, the Journal of Cell Biology (JCB) and Blood had reported that 20-28% of accepted manuscripts had signs of image manipulation. 2, 3 Also, 1% of JCB's accepted manuscripts had manipulations that look like "delib erate falsifications." 2 Representing the results of a self-audit by the community in the normal conduct of research, a level of 1% is consistent with the inci dence of suspected falsification re ported by scientists in the recent Gallup study. 2 So what happens to the allegations? The ORI case load involving falsified im ages is roughly 10-100 fold less than one would predict from the 1% sus pected. 2, 4 Are the rejected manuscripts
RRI Funding Opportunity
Partnering with ORI this year will be the Eunice Kennedy Shriver National Insti tute of Child Health and Human Devel opment, and the National Center for Re search Resources (NCRR). NCRR also will provide administration at all stages of the grant process, including the review process (the past review had been done at CSR).
The format for 2009 reasearchers who are interested in conducting research on re search integrity (RRI) will use the R21 mechanism. The R21 directs researchers to focus on questions in the context of research collaborations. The proposed projects for the R21 mechanism must challenge existing paradigms, be devel oped around an innovative hypothesis, or address critical barriers to progress in un derstanding the multiple factors that un derlie significant departures from research integrity. Proposals must have clear rel evance to biomedical, behavioral health sciences, or health services research. The conference addressed problems that arise in cross-national collaborations. When something goes wrong in an inter national collaboration, everyone involved readily blames miscommunication, mis understanding, or misinterpretation of rules or requirements.
Deadline for applications is
Only as a case unfolds will the fundamen tal differences in the way science is done in various countries appear as contribut ing factors.
The conference examined four fundamen tal differences in four areas: (a) the orga nization and funding of science, (b) cul tural expectations, (c) legal and regulatory environments, and (d) the training of graduate students and postdoctoral fellows.
Image Manipulation
International differences can lead to sub stantially different assumptions and ex pectations about how research projects are to be planned, performed, and re ported. Unless scientists are fully abreast, they may not comprehend the critical need for explicit attention to aspects of research projects. Many will take for granted vari ous areas of concern-such as compli ance with national policies, authority within the administrative hierarchy, and responsibilities of postdocs. Without ex plicit attention to all aspects of the re search, ethical problems and misconduct may happen.
Conference speakers had collective expe riences in international research collabo rations in over 60 countries and described first-hand experiences in international col laborations.
Many problems are common to all scien tific collaborations but are complicated by cross-national differences in oversight and expectations.
Other problems are unique to the interna tional arena, and their solutions often de pend on commitment and trust developed through long-term collaborative associa tions.
There is great interest in international sci entific collaborations, because of their po tential for stimulating, creative, and pro ductive interactions. On-line project management and improved communica tion technology have made such collabo rations easier to develop and maintain.
Attendees left the conference with a sense that international collaborations are much more complicated than they had realized. They repeatedly used the word "daunting" to describe the prospect of handling the challenges of international research. Woven throughout the tracks will be content threads and certificate pro grams. SRA's participants come from universities, government, healthcare providers, non-profits, foundations, and commercial settings, making the meeting unique in its ability to build research management competency at all levels-from novices, to "tweeners," to senior executives.
Managing a Research
Please check the SRA web site at http:// srainternational.org/ ing: universities, government agencies, research institutions, and healthcare and academic medical centers.
As society increasingly invests in the importance of research and develop ment for human progress and for the advancement of the quality of human life, the leadership of research admin istrators, whether executives or tech nical staff, is equally important to guarantee that the human benefits of research are realized continually now and into the future. We are currently addressing these ques tions with a new research effort to develop a tool-the Uniform Research Integrity Climate Assessment (U-RICA). We be lieve such a tool will provide university leaders with valuable insights about the climates and sub-climates within their institutions.
Annual Report Time
Over the next two years, we will assess, es tablish, and validate the psychometric prop erties of our instrument by surveying a large, nested, random sample of ~2,500 re searchers based in roughly 20 academic health centers across the United States.
To facilitate adoption of the tool, we are partnering with a group of opinion lead ers from within the ethics cores of sev eral universities that currently hold Clini cal and Transitional Science Awards (CTSAs) to conduct feasibility analyses. We identify opportunities, stakeholders, and possible strategies as well as per ceived risks, potential hurdles, and threats facing the success of propagating use of this tool in the CTSA Consortium.
In addition, a preliminary version of this instrument will be used by multiple uni versities to assess their climates as part of the Project for Scholarly Integrity be ing conducted by the Council of Gradu ate Schools.
We believe that the findings from our re search and application with multiple uni versities will provide convincing evidence on the value of self-assessment and will diminish resistance and concerns of do ing an institutional self-review. Studying this population of investiga tors allows for two important evalua tions. It will afford an analysis of the RCR training experiences of K recipi ents along with an assessment of their acquired skills and competence. Sec ond, given the K program's require ments for a mentoring relationship, the role of the mentor in teaching, model ing, and encouraging RCR in the train ing component can be evaluated.
New Research on Research Integrity Publications
A web-based survey of K awardees (ap proximately 3,200) and their mentors will be conducted. The findings from this study will help determine what com ponents of RCR training are important for RCR knowledge and application of the recipient. Information regarding the influence of both general mentoring and specific RCR mentoring will be ana lyzed. Areas of strength and weakness with RCR training and mentoring will be identified and can be used to help formulate recommendations to improve RCR training and mentoring for young investigators.
Office of Research Integrity n e w s l e t t e r

Research Misconduct
A Plan to Prevent and Respond to Plagiarism Complaints Blacklisting
(from page 1)
Jeremy Graham, M.S., M.S.Ed., and I be gan by setting the parameters for build ing a database containing the policies and pronouncements on authorship and plagiarism from the four elements of our RRC framework. For "Institution," we set up a web page with definitions and a decision tree based on the CUNY policy.
For "Publications," we searched for all articles by Baruch College faculty from 2002 to the present and compiled a list of 604 publications. We visited the web sites of each journal and recorded their authorship and plagiarism policies (or lack thereof) into a database tagged by department and discipline.
For each "Discipline," we are compil ing a list of professional societies and organizations in which faculty members have made presentations since 2002.
We are also working on the "Funding" domain: we will compile a list of agencies that have funded members of the Baruch College faculty since 2002 and list their requirements. We plan to define and de velop a policy dataset for disciplines and funding agencies that will be similar to the publication database. The development and administration of international research collabora tions, however, present some major challenges. The I-Group is charged with seeking a more structured ap proach to international research collabo rations and designing an administrative infrastructure that can help govern ments, companies, and universities manage a wide range of administrative and legal complexities. Figures  5E and 6E, respectively.
Implementation of RRC
RIO Boot Camp UPDATE
• Respondent falsified Figure 6A depict ing wild type and GCNF-/-embryonic stem cells to compare the binding of GCNF, MBD2, and MBD3 to the Oct4 gene and the measurement of expres sion at the RNA and protein levels by deleting in Photoshop the GCNF West ern blot data in the GCNF-/-cells (to match the lack of expression at the RNA level) and falsified the MBD 2 West ern blot data in the GCNF-/-cells (or that depicted in Figure 7C , which shows the exact same data but reportedly from DNA methylation-deficient embryonic stem cells [Dnmt3A/Dnmt3B/ES cells]).
• Respondent falsified the MBD2 wild type and GCNF-/-chromatin Immuno precipitation (ChIP) data in Figure 6B . • In Figures 3C and 3D , depicting trans fected wild-type and mutated HA GCNF expression levels in undifferen tiated and differentiated P19 cells, Respondent planned not to show the data for the Asp307 mutant (the data for the Asp307 mutant were deleted in panel D); however, she falsified Figure  3C by deleting the least intensive band instead of the Asp307 mutant in order to make the overall data appear more consistent and support the claim that there were no significant differences in the expression levels between the GCNF mutants and the wild type HA GCNF in P19 cells.
• In Figure 4A , Respondent intended not to show each figure where non-specific bands were not visible in the original data. The data for the Asp307 mutant: she falsified the reported results by de leting the least intensive band instead of the Asp307 mutant in order to make the overall data appear more consistent in support of the claim that all mutants were expressed at similar levels in COS1 cells and that the various point mutations had not altered the stability of the protein.
• Respondent falsified Figure 5A , which reported the detection of HA-GCNF point mutant expression in retinoic acid-differentiated P19 cells by West ern blot with anti-HA antibody, by du plicating a series of lanes in the pub lished figure: Lane 2 is the same as lane 4; lane 3 is the same as lanes 5, 7, and 9, and lane 6 is the same as lanes 8, 10, and 11.
• Respondent falsified Figure 6C , which reported on the dimerization abilities of various GCNF mutants, by cutting and pasting (in Photoshop) bands into original lanes 7 and 8 to demonstrate the homodimer; certain of the compari sons reported in the text describing this figure do not appear to be confirmed in a repeat experiment. • Respondent falsified Figure 1A by cut ting out lanes and relocating them, wild type GCNF lanes 7 and 8 of the origi nal data becoming lanes 1 and 2 in the published figure; the effect of the falsi fication was to demonstrate the inverse correlation with expression of Oct4, which did not appear to be confirmed in a repeat of the experiment.
• Respondent falsified Figure 4A by switching the 6 hour and 12 hour Oct4 expression data in the wild type embry onic stem cells (these falsified data also appear in Figure 5B ).
Dr. Gu has entered into a Voluntary Settle ment Agreement (Agreement) in which she has voluntarily agreed, for a period of three (3) years, beginning on Septem ber 12, 2008:
(1) To exclude herself from serving in any advisory capacity to PHS, including but not limited to service on any PHS advi sory committee, board, and/or peer review volume 17, no. 1 http://ori.hhs.gov December 2008
Case Summaries (continued) committee, or as a consultant or contrac tor; and (2) That any institution that submits an application for PHS support for a research project on which the Respondent's par ticipation is proposed or that uses the Respondent in any capacity on PHS-sup ported research, or that submits a report of PHS-funded research in which the Re spondent is involved, must concurrently submit a plan for monitoring of the Respondent's research to the funding agency and ORI for approval. The moni toring plan must be designed to ensure the scientific integrity of the Respondent's re search contribution. Respondent agreed that she will not participate in any PHSsupported research until such a monitor ing plan is submitted to ORI and the fund ing agency.
Dr. Gu also agreed that she would imme diately cooperate with BCM officials to request retraction of the MBD paper. In the retraction letter, she will state that she alone was responsible for the falsification and fabrication of some of the data re ported in the paper. Specifically, PHS found that the Respon dent committed misconduct in science:
• By intentionally and knowingly prepar ing and including duplicate image data • by preparing and providing to his dis sertation committee in March 2000 a thesis proposal entitled "An Alternate Mechanism of Neurodegeneration: Si lencing of Insulin-like Growth Factor-I survival signals by Tumor Necrosis Factor-alpha," which contained five fal sified figures: Figures 1.3, 1 .4a, 2.1b, 2.3e, and 2.5b. In each figure, he re used data within the same figure or in another thesis proposal figure as repre senting differently treated samples or as data obtained with different immuno blotting antisera.
• 3, 3.4a, 3.4b, 4.1b, 4.3a, 4.5b, 5.1a, 5.2, 5.4a, 5.5a, 5.6a, 5.7a, and 5.8a (1) That any institution that submits an application for PHS support for a research project on which the Respondent's par ticipation is proposed or that uses the Re spondent in any capacity on PHS-sup ported research, or that submits a report of PHS-funded research in which the Re spondent is involved, must concurrently submit a plan for monitoring of the Respondent's research to the funding agency and ORI for approval; the moni toring plan must be designed to ensure the scientific integrity of the Respondent's research contribution; Respondent agreed that he will not participate in any PHSsupported research until such a monitor ing plan is submitted to ORI and the fund ing agency;
(2) That Respondent will ensure that any institution employing him will submit to ORI, in conjunction with each application for PHS funds or report, manuscript, or abstract of PHS-funded research in which the Respondent is involved, a certifica tion that the data provided by the Respon dent are based on actual experiments or are otherwise legitimately derived, and that the data analyses, procedures, and methodology are accurately reported in the application or report; Respondent must ensure that the institution sends a copy of each certification to ORI; and (3) To exclude himself from serving in any advisory capacity to PHS, including but not limited to service on any PHS advi sory committee, board, and/or peer review committee, or as a consultant or contrac tor to PHS.
Respondent also voluntarily agreed that within 30 days of the effective date of this Agreement:
Office Figures 1A, 2 , 4A, 4B, and 7; by duplicating and reusing lanes of polyacry lamide gels in Figure 3 , of Western blot analyses in Figures 5A, 5C , 6C, and 9, and of agarose gels in PCR analyses in Figure 5B ; and by duplicating and reus ing laser confocal micrographs in Figures  10 and 11 . Respondent's claims that Fig  ures 1A , 2, 4A, and 7 were representative of experiments repeated five times and that Figures 3, 4B , 5A, 6C, and 9 were representative of experiments repeated three times constitute additional falsifi cations. The effect of these misrepresen tations was to falsely demonstrate the proapoptotic activity of a protein from a novel cDNA clone isolated from an HIVinfected human macrophage cell line and to falsify its presence in brain and lym phoid tissue from patients with HIV-as sociated dementia.
2. In Figure 10 reported in RakoffNahoum, S., Chen, H., Kraus, T., George, I., Oei, E., Tyorlin, M., Salik, E., Beuria, P., & Sperber, K. Figure 3B ; by reusing the same FACS histogram as the negative control for CD-4 cells and for the CD-8 cells in Figure 4B ; and by du plications of the top two panels, the middle two panels, and the bottom two panels of data as graded dilutions of dif ferent fractions in Figure 6B to falsely show that a soluble factor from 43HIV cells induced apoptosis. Figure 6B was also presented in grant application AI45343-01A1 as Figure 5B . Respon dent's reported claims that the results in Figures 3B, 4B , and 6B were each repre sentative of experiments that were re peated three times constitute additional falsifications.
PHS also finds that Respondent engaged in scientific misconduct by falsifying and fabricating the following data in NIAID, NIH, research applications R01 AI45343 04A2 and P01 AI44236-05:
4. The results of Figures 1, 6C , 7, 9, 10, and 11 from the 2003 J. Immunology pa per were reported in NIAID, NIH, grant application R01 AI45343-04A2; nearly all of the figures in the paper were falsi fied, so that the claims in the grant appli cation derived from those figures were also false. 5. Two figures in NIAID, NIH, grant application P01 AI44236-05 con tained falsified data: In Figure 1b , pan els of confocal microscopy images of in testinal biopsies from four patients were falsified by duplication; and in Figure 3 , one panel of PCR data was duplicated and similarly misrepresented as data from the same four biopsy specimens. PHS finds the Respondent engaged in scientific misconduct by falsifying and fabricating data that were reported in a scientific manuscript intended for publi cation entitled "Increased renin transcrip tion after inhibition of NF-YA with RNAi reveals through regulation of Ea element and Ear2" and at two professional scien tific meetings.
Specifically, PHS found that:
1. Respondent falsified Figure 1 in the manuscript that purports to show the ef fectiveness of four plasmids targeting dif ferent parts of the NF-Y coding sequence in inhibiting NF-Y expression by:
• Claiming in Figure 1A that the loading control bands were obtained by reprobing a Western blot with antibody to GAPDH when he used a prominent background (nonspecific) band from the blot probed with antibody to NF-YA;
• Inappropriately enhancing and manipu lating the NF-YA band in Figure 1A claiming decreased expression of NF YA in cultures transfected with 2 of the 4 constructs, and;
• Falsely claiming in Figure 1B that the quantitative data for NF-YA expression obtained by scanning Western blot films were based on an n of 4 and that the expression of NF-YA in cultures treated with two constructs was statistically sig nificantly lower than the control. Ver sions of the same falsified blot and his togram also were reported in several of Respondent's public presentations. Respondent stated that he does not intend to apply for or engage in PHS-supported research. However, if such a circumstance were to arise, Respondent agreed for a period of five (5) years, beginning on October 14, 2008:
(1) That any institution that submits an application for PHS support for a research project on which the Respondent's par ticipation is proposed or which uses him in any capacity on PHS-supported re search, or that submits a report of PHSfunded research in which he is involved, must concurrently submit a plan for su pervision of the Respondent's duties to the funding agency for approval; the su pervisory plan must be designed to en sure the scientific integrity of the Respondent's research contribution; Re spondent agreed to ensure that a copy of the supervisory plan is also submitted to ORI by the institution; Respondent agreed that he will not participate in any PHSsupported research until such a supervi sion plan is approved by ORI; and (2) That any institution employing the Respondent submits, in conjunction with each application for PHS funds or report, manuscript, or abstract of PHS-funded re search in which he is involved, a certifi cation that the data provided by the Re spondent are based on actual experiments or are otherwise legitimately derived, and that the data, procedures, and methodol ogy are accurately reported in the appli cation or report; the Respondent must ensure that the institution also sends a copy of the certification to ORI; and (3) To exclude himself from serving in any advisory capacity to PHS, including but not limited to service on any PHS advi sory committee, board, and/or peer review committee, or as a consultant.
DISCLAIMER
All authors who generously shared their thoughts have indicated that they are speaking for themselves and not for their specific organizations.
